CORD-19:8ba20a12c92103d82364b8abca49cfcd91d91c13 / 0-131
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":123,"end":131},"obj":"Sentence"},{"id":"TextSentencer_T1","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":123,"end":131},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients NIH Public Access Author Manuscript\n\nAbstract"}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1","span":{"begin":61,"end":76},"obj":"Disease"},{"id":"T84499","span":{"begin":61,"end":76},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A62994","pred":"mondo_id","subj":"T84499","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"}],"text":"N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients NIH Public Access Author Manuscript\n\nAbstract"}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T1","span":{"begin":61,"end":76},"obj":"Phenotype"},{"id":"T2","span":{"begin":70,"end":76},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0012125"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients NIH Public Access Author Manuscript\n\nAbstract"}